The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Abstract
BACKGROUND: Concomitant with the recent emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs), Escherichia coli has become the enterobacterial species most affected by ESBLs. Multiple locales are encountering CTX-M-positive E. coli, including specifically CTX-M-15. To gain insights into the mechanism underlying this phenomenon, we assessed clonality and diversity of virulence profiles within an international collection of CTX-M-15-positive E. coli. METHODS: Forty-one ESBL-positive E. coli isolates from eight countries and three continents (Europe, Asia and North America) were selected for study based on suspected clonality. Phylogenetic group, ERIC2 PCR profile, O H serotype, AmpC variant and antibiotic susceptibility were determined. Multilocus sequence typing (MLST) and PFGE provided additional discrimination. Virulence potential was inferred by detection of 46 virulence factor (VF) genes. RESULTS: Thirty-six (88%) of the 41 E. coli isolates exhibited the same set of core characteristics: phylogenetic group B2, ERIC2 PCR profile 1, serotype O25:H4, AmpC EC6, ciprofloxacin resistance and MLST profile ST131. By PFGE, the 36 isolates constituted one large cluster at the 68% similarity level; this comprised 17 PFGE groups (defined at 85% similarity), some of which included strains from different countries. The 36 isolates exhibited highly (91% to 100%) similar VF profiles. CONCLUSIONS: We describe a broadly disseminated, CTX-M-15-positive and virulent E. coli clonal group with highly homogeneous virulence genotypes and subgroups exhibiting highly similar PFGE profiles, suggesting recent emergence. Understanding how this clone has emerged and successfully disseminated within the hospital and community, including across national boundaries, should be a public health priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Rapid and Simple Determination of the Escherichia coli Phylogenetic Group
Clermont, O., Bonacorsi, S., & Bingen, E. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.10.4555-4558.2000 · Cited by 2,645
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Self-citationManges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Self-citationMcGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefévre, J. C., Tomasz, A., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2565-2571.2001 · Cited by 518
Oliveira, D. C., Tomasz, A., & de Lencastre, H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00227-x · Cited by 494
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Analysis of a Uropathogenic Escherichia coli Clonal Group by Multilocus Sequence Typing
Tartof, S. Y., Solberg, O. D., Manges, A. R., & Riley, L. W. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5860-5864.2005 · Cited by 248
Johnson, J. R., Kuskowski, M. A., Owens, K., Gajewski, A., & Winokur, P. L. (2003) · The Journal of Infectious Diseases · doi:10.1086/377455 · Cited by 246
Self-citationSwaminathan, B., Gerner-Smidt, P., Ng, L.-K., Lukinmaa, S., Kam, K.-M., Rolando, S., Gutiérrez, E. P., & Binsztein, N. (2006) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2006.3.36 · Cited by 228
Moubareck, C. A., Daoud, Z., Hakimé, N., Hamzé, M., Mangeney, N., Matta, H., Mokhbat, J., Rohban, R., Sarkis, D. K., & Doucet‐Populaire, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3309-3313.2005 · Cited by 173
Johnson, J. R., Clermont, O., Menard, M., Kuskowski, M. A., Picard, B., & Denamur, E. (2006) · The Journal of Infectious Diseases · doi:10.1086/507305 · Cited by 161
Self-citationMendonça, N., Leitão, J., Manageiro, V., Ferreira, E., & Caniça, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01412-06 · Cited by 160
Self-citationLavollay, M., Mamlouk, K., Frank, T., Akpabie, A., Burghoffer, B., Redjeb, S. B., Bercion, R., Gautier, V., & Arlet, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00150-06 · Cited by 155
Leflon‐Guibout, V., Jurand, C., Bonacorsi, S., Espinasse, F., Guelfi, M.-C., Duportail, F., Heym, B., Bingen, É., & Nicolas-Chanoine, M.-H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3736-3742.2004 · Cited by 149
Self-citationClermont, O., Johnson, J. R., Menard, M. L., & Denamur, É. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.08.007 · Cited by 130
Self-citationCarriço, J. A., Pinto, F. R., Simas, C., Nunes, S., Gonçalves‐Sousa, N., Frazão, N., de LENCASTRE, H., & Almeida, J. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5483-5490.2005 · Cited by 124
Pitout, J. D. D., Laupland, K. B., Church, D. L., Menard, M. L., & Johnson, J. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4667-4670.2005 · Cited by 105
Self-citationJohnson, J. R., Kuskowski, M. A., O’Bryan, T. T., & Maslow, J. N. (2002) · The Journal of Infectious Diseases · doi:10.1086/340506 · Cited by 97
Self-citationJohnson, J. R., & O’Bryan, T. T. (2000) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.2.265-273.2000 · Cited by 95
Self-citationPallecchi, L., Malossi, M., Mantella, A., Gotuzzo, E., Trigoso, C., Bartoloni, A., Paradisi, F., Kronvall, G., & Rossolini, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4556-4561.2004 · Cited by 94
Escherichia coli Serotype O15:K52:H1 as a Uropathogenic Clone
Prats, G., Navarro, F., Mirelis, B., Dalmau, D., Margall, N., Coll, P., Stell, A. L., & Johnson, J. R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.201-209.2000 · Cited by 66
Self-citationGangoué‐Piéboji, J., Miriagou, V., Vourli, S., Tzelepi, Ε., Ngassam, P., & TZOUVELEKIS, L. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.441-443.2005 · Cited by 56
Boczek, L. A., Rice, E. W., Johnston, B., & Johnson, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02225-06 · Cited by 51
Self-citationArpin, C., Coulange, L., Dubois, V., André, C., Fischer, I., Fourmaux, S., Grobost, F., Jullin, J., Dutilh, B., Couture, J.-F., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01431-06 · Cited by 22
Cited by
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Self-citation
Metadata
- Authors
- Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-19
- Volume
- 61
- Issue
- 2
- Pages
- 273-281
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2144148663
- Cited by
- 821
- References
- 29
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.